Nautilus Biotechnology Reports Q3 Operating Expenses of $16.947 Million
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
10:02:08 AM UTC
SquawkNews
Oct 27 (Reuters) - Nautilus Biotechnology Q3 operating expenses USD 16.947 million.